Unilever Sverige AB has sold Opus Healthcare AB to Segulah
Unilever Sverige AB (Unilever), based in Sweden, has sold its subsidiary Opus Healthcare AB (Opus) to Segulah, a private equity firm, for an undisclosed consideration.
Opus is a leading provider of products with strong brands and leading market positions within the disinfection (DAX), oral care (Zendium) and cleaning (Neutral) sectors.
Segulah is a private equity firm based in Stockholm, Sweden. The company owns and develops mid-market companies and invests in buyouts of profitable, stable businesses run by experienced management teams.
Unilever, with with more than 400 brands focused on health and wellbeing Unilever's portfolio ranges from nutritionally balanced foods to indulgent ice creams, affordable soaps, luxurious shampoos and everyday household care products. The company produces world-leading brands including Lipton, Knorr, Dove, Axe, Hellmann’s and Omo, alongside trusted local names such as Blue Band, Pureit and Suave.
Oaklins' team in Sweden was engaged as advisor to manage the process when Unilever wanted to explore new ownership options for Opus.
Talk to the deal team
Related deals
Perkbox has been acquired by Great Hill Partners
Molten Ventures has sold Perkbox to Great Hill Partners.
Learn moreArculus Cyber Security has been acquired by Bridewell
The shareholders of Arculus Cyber Security (Arculus) have sold the business to Bridewell. The deal will bolster Bridewell’s growing roster of accreditations as well as strengthen its public sector footprint, enabling the expansion of its end-to-end cyber security offering for clients across the globe.
Learn moreGlobal IT Group has joined forces with enthus Group
Global IT Group, an IT services company, and enthus Group GmbH, an IT solution provider operating in Germany, Austria and Switzerland, have joined forces. As a result, enthus Group will significantly expand its market position in Switzerland. The sellers of Global IT have reinvested in the buyer and will ensure that local management continues to run the company as part of the succession planning.
Learn more